A Zhu, D Lee, H Shim - Seminars in oncology, 2011 - Elsevier
Positron emission tomography (PET) is a noninvasive imaging technique that provides a functional or metabolic assessment of normal tissue or disease conditions. Fluorine 18 …
K Herholz, KJ Langen, C Schiepers… - Seminars in nuclear …, 2012 - Elsevier
This review addresses the specific contributions of nuclear medicine techniques, and especially positron emission tomography (PET), for diagnosis and management of brain …
C Juhász, S Dwivedi, DO Kamson… - Molecular …, 2014 - journals.sagepub.com
Positron emission tomography (PET) is an imaging technology that can detect and characterize tumors based on their molecular and biochemical properties, such as altered …
BJ Fueger, J Czernin, T Cloughesy… - Journal of Nuclear …, 2010 - Soc Nuclear Med
6-18F-fluoro-l-dopa (18F-FDOPA) measured with PET as a biomarker of amino acid uptake has been investigated in brain tumor imaging. The aims of the current study were to …
Positron emission tomography (PET) imaging with the amino acid tracer 6-18 F-fluoro-l-3, 4- dihydroxy-phenylalanine (18 F-DOPA) may provide better spatial and functional information …
Purpose: This study compares the value of 3, 4-dihydroxy-6-[18F]-fluoro-l-phenylalanine (18F-FDOPA) positron emission tomography (PET) and MRI in assessing outcome during …
Purpose Positron emission tomography (PET)/computed tomography (CT) has become a critical tool in clinical oncology with an expanding role in guiding radiation treatment …
S Karunanithi, P Sharma, A Kumar… - European journal of …, 2013 - Springer
Purpose Differentiation between recurrence and radiation necrosis in patients with glioma is crucial, since the two entities have completely different management and prognosis. The …
The current study examined the use of voxel-wise changes in 18F-FDOPA and 18F-FLT PET uptake, referred to as parametric response maps (PRMs), to determine whether they were …